Equities

Medinex Ltd

Medinex Ltd

Actions
Health CareHealth Care Providers
  • Price (SGD)0.20
  • Today's Change0.00 / 0.00%
  • Shares traded1.20k
  • 1 Year change--
  • Beta0.3869
Data delayed at least 10 minutes, as of Oct 04 2024 09:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SGDIncome statement in SGDView more

Year on year Medinex Ltd's net income fell -39.23% from 1.70m to 1.03m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 39.71% to 42.12%.
Gross margin76.89%
Net profit margin6.89%
Operating margin7.13%
Return on assets4.02%
Return on equity6.13%
Return on investment4.74%
More ▼

Cash flow in SGDView more

In 2024, Medinex Ltd increased its cash reserves by 24.52%, or 1.02m. The company earned 2.70m from its operations for a Cash Flow Margin of 21.43%. In addition the company generated 1.66m cash from investing, though they paid out 3.33m more in financing than they received.
Cash flow per share0.012
Price/Cash flow per share16.69
Book value per share0.1215
Tangible book value per share0.0548
More ▼

Balance sheet in SGDView more

Medinex Ltd has a Debt to Total Capital ratio of 11.43%, a higher figure than the previous year's 8.64%.
Current ratio2.57
Quick ratio2.44
Total debt/total equity0.1293
Total debt/total capital0.1143
More ▼

Growth rates in SGD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -39.27%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)215.74%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-39.42
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.